Introduction
Liver cirrhosis is the end-stage disease of chronic liver injury. Cirrhosis is caused by different etiological factors; however, progression of liver injury varies considerably among individuals independently of the cause [1] . Different research groups over the last decade have attempted to identify crucial cofactors that contribute to the development of liver damage [2, 3] . A growing number of studies show that, apart from the main underlying causative agent in liver cirrhosis, the process may be reinforced by confounding factors such as diet, alcohol consumption, etc. [4] [5] [6] . Interindividual variation of time span from normal liver to fibrotic and cirrhotic stages suggested potential influence of congenital variations. Advances in genotyping techniques allowed to identify coexisting genetic alterations in relation to liver fibrosis [6] and cirrhosis of different etiologies [4, 7] .
C282Y and H63D mutations of the HFE gene are now recognized as the most common genetic disorders in populations of European ancestry. Carriage of heterozygous hemochromatosis (HH) gene mutations has been attributed as the risk factor of iron overload and liver damage, but equivocal conclusion on the role of these mutations has not been achieved [8, 9] . The rationale that suggested iron as a susceptible hepatotoxic factor is based on the ability of this metal to induce oxidative stress by stimulating free radical formation in liver tissue [10, 11] . Furthermore, increased contents of iron have been attributed to progression to liver cirrhosis of chronic viral hepatitis C (HCV) infection [12] , nonalcoholic fatty liver disease (NAFLD) [11] or alcoholic liver disease (ALD) [13] .
As noted above, development of liver cirrhosis regardless of etiology in separate individuals may have enormous variation in terms of time frame and severity. Carriage of HFE gene mutations has been linked with increased risk of liver fibrosis or liver cirrhosis; however, published studies report conflicting results [8] . The presence of the C282Y mutation was associated with more advanced degrees of fibrosis or cirrhosis [12, 14] , but these findings were not confirmed in other studies [11, 15] . The prevalence of HFE C282Y mutations varies significantly across Europe, with highest estimated in Ireland (>10%), intermediate frequencies (2.7%-7%) in neighboring countries Latvia [16] and Poland [17] , and very low rates of (0%-2%) in Mediterranean areas [18] . HFE H63D mutation also occurs at different frequencies in separate regions [18] . Therefore, the discordance among the findings in previous studies on association of HFE mutations with non-HH liver cirrhosis/fibrosis might be related to variations in study design and differences in HFE mutation prevalence in individual populations.
In this study we performed analysis of HFE gene C282Y and H63D mutations in consecutive 209 cirrhotic patients and 1005 voluntary, unrelated blood donors of the Caucasian ethnicity. The aim of this study was to determine the association between HFE gene C282Y and H63D mutations and liver cirrhosis in the Lithuanian population. This was the first study assessing the prevalence of HFE gene mutations in Lithuanian cirrhotic patients and adds additional insights on the impact of HFE mutations in development of non-HH cirrhosis.
2.
Materials and methods 
Patients and control subjects

DNA extraction and genotyping
Genomic DNA was isolated from whole blood containing EDTA by using salting-out procedure. HFE mutations C282Y c.845 G> A (p.Cys282Tyr) and H63D c.187 C>G (p.His63Asp) were detected after DNA amplification by polymerase chain reaction and restriction with RsaI (for C282Y) and BclI (for H63D). For identification of the C282Y mutation, the fragment was amplified using primer forward consisted of an initial denaturation at 95 8C for 5 min, followed by 30 cycles of denaturation at 95 8C for 30 s, annealing at 56 8C for 30 s, and extension at 72 8C for 30 s with final extension at 72 8C for 10 min. The restrictions reactions were performed according manufacturer's protocol. The RFLP fragments were analyzed electrophoretically in 3% of agarose gel.
Statistical analysis
The distribution of HFE genotypes in both cases and controls was examined for deviation from Hardy Weinberg equilibrium (HWE) using the chi-square ( x 2 ) test in each single nucleotide polymorphism (SNP). Comparisons of carriage frequencies for alleles between cases and controls were analyzed by Pearson chi-square and Fisher exact tests. Association analysis based on the case-control design was performed for each SNP by using the Armitage trend test. To estimate relative risks for mutations, odds ratios (ORs) and 95% confidence intervals (95% CI) were calculated using recessive and dominant models. A P value of 0.05 was defined to be statistically significant. Statistical analysis was performed using statistical software for genetic association studies PLINK v2.050 [21] .
Results
Characteristics of the study group
The characteristics of the study groups are presented in . In more detail, the control group was described in our previous study [20] .
Association between HFE C282Y mutation and liver cirrhosis
The association between HFE C282Y mutation and liver cirrhosis is presented in Table 2 . The carriage of C282Y risk allele was significantly more frequent in patients with liver cirrhosis than in controls (OR = 2.1, P = 0.005). This association was also evident in genotypic analysis where heterozygous genotype C282Y/wt and wt/wt carriers were compared (OR = 2.0, P = 0.01) and in recessive model (OR = 2.1, P = 0.007). 
Gender-based stratification analysis revealed significant gender-related differences in the carriage of C282Y mutation between liver cirrhosis patients and controls (Tables 3 and 4 ). The carriage of heterozygous C282Y/wt genotype in men was associated with liver cirrhosis (OR = 2.48, P = 0.008), whereas no significant associations were found in the female group (Table 4) .
Association between HFE H63D mutation and liver cirrhosis
Genotyping analysis of HFE gene H63D mutation did not reveal significant association with liver cirrhosis ( Table 2 ). The carriage of H63D alleles was distributed equally in the control (15.5%) and cirrhotic groups (18.1%, P = 0.244). However, significant gender-related differences were revealed in carriage of H63D mutation between liver cirrhosis patients and controls (Tables 3 and 4 ). The carriage of H63D risk allele (OR = 1.54, P = 0.02) and homozygous H63D/H63D genotypes (OR = 4.13, P = 0.005) were associated with liver cirrhosis in men, but not women.
3.4.
Association between the carriage of two or more HFE gene alleles and liver cirrhosis Carriage of two or more risk alleles was significantly higher in the group of patients with liver cirrhosis than in controls and resulted in significant association (7.66% vs. 3.98%, P = 0.021; 2 0 1 6 ) 2 6 9 -2 7 5 OR = 2.00, 95% CI = 1.10-3.64). Gender-based analysis revealed that in male patients relative risk was increased when bearing two or more risk alleles compared with controls (11.22% vs. 3.78%, P = 0.001; OR = 3.22, 95% CI = 1.54-6.71), whereas no significant difference was observed in women. The prevalence of particular C282Y/H63D compound heterozygous genotype in Lithuanian cirrhotic patients is presented in Table 2 . Only a small number of individuals were carriers of the C282Y/H63D genotype, and the difference between cirrhotic patients and controls was not significant.
Discussion
The major finding of our present study is a significant genderrelated association of C282Y and H63D mutations in the HFE gene with liver cirrhosis in the Lithuanian population. The impact of HFE mutations was found to be significant in male, but not in female subjects. These data suggest that HFE mutations may contribute to hepatic fibrogenesis process during the natural history of chronic liver diseases. This is the first study to assess the prevalence of HFE gene C282Y and H63D mutations in Lithuanian cirrhotic patients. Individuals with chronic liver diseases may have mild to moderate iron overload, but the mechanism behind this phenomenon in not fully understood [22] . Increased hepatic iron content is known to have the potential to exacerbate liver injury [10, 11] . Furthermore, different groups have provided evidence that levels of iron near the upper limit of normal are associated with different pathological processes including cardiovascular diseases and even cancer [23] [24] [25] . C282Y and H63D are the most common mutations causing HH in Caucasians, but studies over the last years have revealed that these mutations have lower penetration than previously estimated, and cannot be advocated alone for the development of HH [26] . Elevated liver enzymes were observed only in 30% of males, while elevated transferrin saturation in combination with an elevated ferritin was present in 43.4% of males and 23.3% of females homozygous for C282Y [26] . Further studies showed that cirrhosis was diagnosed only in 6% of males and in 2% of females in a population-based screening setting among C282Y homozygotes [27] . Nevertheless, even carriage of heterozygous C282Y and H63D variants has been suggested to increase iron overload and exacerbate chronic non-HH related liver injury [12, 14] .
Studies in different populations examining the relationship between HFE mutations and chronic liver diseases have produced varying outcomes. A study including 587 patients from Italy with NAFLD and 184 control subjects did not find a link between HFE mutations and hepatocellular iron accumulation [11] . A Canadian study has demonstrated that Caucasian C282Y heterozygotes were more likely to have bridging fibrosis or cirrhosis in non-alcoholic steatohepatitis (NASH) [14] , meanwhile this link was not present in a study by Chitturi et al. [15] . A Polish study conducted by Raszeja-Wyszomirska et al. showed a trend toward a more common occurrence of ALD in individuals homozygous for the H63D mutation [28] , while another study found no differences in the prevalence of HFE mutations between Polish cirrhotic patients and healthy individuals [29] . C282Y or H63D heterozygosity was found as an independent risk factor for liver fibrosis and cirrhosis in a German study including 401 patients with chronic HCV infection and 295 healthy controls [30] . The presence of HFE mutations was independently associated with iron loading and advanced fibrosis in patients with HCV, especially after controlling for duration of disease [12] . Whereas, a Scottish study has shown that carriage of HFE mutations does not have any role in the accumulation of iron or the progression of liver disease in HCV infection [31] . Similar results were observed in the Czech study which has demonstrated that HFE mutations do not play an important role in the pathogenesis of chronic hepatitis B, chronic hepatitis C or alcoholic liver disease [32] . Interestingly, an Indian study has observed significant associations of common HFE mutations (C282Y and H63D) with HCV and ALD related liver cirrhosis, even though the mutations are relatively rare in this population [33] . Another study in non-European population has suggested that iron overload and HFE gene mutations do not play a primary role in cryptogenic cirrhosis in the south Iranian population [34] .
Varying results between previous studies have urged us to examine the above-discussed associations in a cohort of Lithuanian cirrhotic patients. The results of our study support those studies that have revealed a significant role of C282Y and H63D mutations in non HH-related liver cirrhosis in Caucasian populations. Overall analysis has revealed that C282Y mutation is associated with liver cirrhosis in our study population, but this observation has not been found for H63D carriers. Gender based stratification analysis of our data revealed that carriage of HFE risk allele C282Y was associated with liver cirrhosis in males, but not in females. Association of liver cirrhosis in men was also evident among the carriers of heterozygous C282Y genotype. Furthermore, in males the carriage of homozygous H63D genotypes were also associated with liver cirrhosis, while this relationship was not present in females. There was a trend for increased risk of liver cirrhosis among female carriers of C282Y mutation, but due to a relatively small sample size the difference did not reach statistical significance. It is well known that the penetrance of HFE C282Y homozygous subjects is higher in males than in females, who, due to physiological mechanisms, are less likely to develop iron overload [22, 27] . As pointed out by Fargion et al., discrepant results that have been reported on the association between HFE mutations and different liver diseases might be influenced by ethnic differences and small sample sizes of the individual studies, as well as by variable penetrance of HFE gene mutations [22] . The strength of our study is a large, well-selected control group, which offers a good representation of the overall Lithuanian population, and which has been used for determination of HFE gene mutation frequencies in Lithuania [20] . Overall, the ultimate role of HFE mutations for chronic liver injury has to be determined in further large-scale, well-designed prospective studies.
The major limitation of our research is the retrospective design of the study. For this reason, full-scale information on iron parameters including ferritin levels, transferrin saturation and hepatic iron content was available only for a small proportion of cirrhotic patients. Due to a relatively small sample size, subgroup analysis in different etiological entities of liver cirrhosis (hepatitis C and B, alcoholic liver disease, etc.) was not performed. In addition, the spectrum of etiology of cirrhosis in a tertiary-level hospital (one having a liver transplantation unit) patients' cohort could be influenced by referral and selection bias. We admit that the relatively small and heterogeneous sample size of cirrhotic patients in our study does not carry high statistical power; however, significant associations between HFE mutations and liver cirrhosis determined by our group suggest a possible role of these genetic alterations in chronic liver diseases.
Conclusions
Heterozygous C282Y mutation of the HFE gene was associated with liver cirrhosis. In gender-related analysis, heterozygous C282Y and homozygous H63D mutations were linked with liver cirrhosis in men, but not in women.
